Nuravax and others are working on the next wave of Alzheimer’s treatments to catch the disease before symptoms arise.

Biogen will pay City Therapeutics $46m, which includes $16m upfront and $30m investment for a convertible note.

News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, Tax Shelters, Insurance bonds. Healthy returns: Japan’s assault on old-age di ...